User:Mr. Ibrahem/Revefenacin

Revefenacin, sold under the brand name Yupelri, is a medication used for the long term treat of chronic obstructive pulmonary disease (COPD). It is used by breathing it into the lungs.

Common side effects include cough, upper respiratory tract infection, headache, and back pain. Other side effects may include allergic reactions, bronchospasm, and urinary retention. It is a long-acting muscarinic antagonist (LAMA).

Revefenacin was approved for medical use in the United States in 2018. It is not available in the United Kingdom or Europe as of 2021. In the United States it costs about 1,100 USD per month.